v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities      
Net loss $ (123,074,000) $ (28,974,000) $ (61,982,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Impairment of other long-lived assets 4,443,000 3,865,000 1,447,000
Depreciation and amortization 48,973,000 59,769,000 56,096,000
Stock-based compensation 31,614,000 33,461,000 30,977,000
Foreign currency transaction loss (gain) 636,000 9,090,000 3,446,000
Gain from step acquisition 0 0 (14,400,000)
Gain from deconsolidation of subsidiary 0 (39,136,000) 0
Share in net (profits) losses of associated companies 32,705,000 5,726,000 (949,000)
Revaluation of investments 5,665,000 3,778,000 (1,301,000)
Revaluation of contingent consideration (21,408,000) (15,805,000) 0
Deferred income taxes, net and uncertain tax positions (1,764,000) 926,000 (12,380,000)
Other non-cash items, net 1,089,000 (2,778,000) 2,914,000
Change in cash attributable to changes in operating assets and liabilities:      
Accounts receivable, net (25,653,000) (28,877,000) (25,003,000)
Inventories 4,571,000 (87,337,000) (53,000)
Other current assets and prepaid expenses 1,553,000 5,758,000 (14,976,000)
Other non-current assets 11,047,000 4,472,000 10,460,000
Accounts payable (27,445,000) 19,614,000 28,492,000
Other current liabilities 4,228,000 (17,707,000) 38,952,000
Deferred revenues 408,000 6,577,000 8,872,000
Other non-current liabilities (9,233,000) (7,827,000) (14,788,000)
Net cash provided by (used in) operating activities (61,645,000) (75,405,000) 35,824,000
Cash flows from investing activities      
Cash paid for business combinations, net of cash acquired (72,118,000) 0 (20,553,000)
Purchase of property and equipment (13,551,000) (13,635,000) (24,981,000)
Investments in short-term bank deposits (111,448,000) (479,852,000) (361,000,000)
Proceeds from short-term bank deposits 208,815,000 561,485,000 129,000,000
Investments in non-marketable equity securities (12,443,000) (69,148,000) (11,779,000)
Purchase of intangible assets (1,476,000) (6,117,000) (1,770,000)
Other investing activities (1,613,000) 54,000 (82,000)
Net cash used in investing activities (3,834,000) (7,213,000) (291,165,000)
Cash flows from financing activities      
Proceeds from public offering, net of issuance costs 0 0 218,850,000
Proceeds from exercise of stock options 11,000 266,000 8,055,000
Payment of contingent consideration (1,339,000) (2,754,000) 0
Other financing activities (188,000) (281,000) 406,000
Net cash provided by (used in) financing activities (1,516,000) (2,769,000) 227,311,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash (827,000) (7,220,000) (893,000)
Net change in cash, cash equivalents and restricted cash (67,822,000) (92,607,000) (28,923,000)
Cash, cash equivalents and restricted cash, beginning of year 150,686,000 243,293,000 272,216,000
Cash, cash equivalents and restricted cash, end of year 82,864,000 150,686,000 243,293,000
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:      
Cash and cash equivalents 82,585,000 150,470,000 243,179,000
Restricted cash included in other current assets 279,000 216,000 114,000
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 82,864,000 150,686,000 243,293,000
Supplemental disclosure of cash flow information      
Income taxes, net of tax refunds 2,152,000 12,550,000 2,418,000
Non-cash investing and financing activities:      
Transfer of inventories to fixed assets 9,551,000 9,212,000 2,673,000
Transfer of fixed assets to inventories 222,000 123,000 977,000
Contingent consideration 2,472,000 0 17,985,000
Right-of-use assets obtained in exchange for new operating lease liabilities 7,142,000 12,057,000 5,955,000
Issuance of Common stock under employee stock purchase plan 5,915,000 2,978,000 0
Issuance of shares as part of Origin acquisition (Refer to Note 2) $ 5,202,000 $ 0 $ 0

Source